HomeProductsSurgical & ICU EquipmentENT RF Plasma Surgical System ...
ENT RF Plasma Surgical System / Plasma Coagulation Machine
₨700,000.00
Low-temperature RF plasma system for ENT tissue cutting, ablation and coagulation; 40–70°C operating range and foot-pedal/flow controls.
Add to wishlist
CategorySurgical & ICU Equipment
- RF plasma-based electrosurgical technology
- Controlled energy delivery
- Designed for tissue coagulation and ablation
- Suitable for ENT surgical procedures
- Compatible with suitable plasma electrodes and accessories
- User-friendly control interface
- Designed for precise surgical energy management
- Professional clinical construction
- ENT surgical procedures
- Turbinate reduction
- Nasal tissue treatment
- Soft-tissue coagulation
- Tissue ablation
- Minimally invasive ENT procedures
- Other compatible electrosurgical applications
Overview
The ENT RF Plasma Surgical System / Plasma Coagulation Machine is a specialized electrosurgical system designed for controlled tissue treatment during ENT procedures. It uses radiofrequency (RF) energy and plasma-based technology to support tissue coagulation, ablation, and reduction with controlled energy delivery. The system is designed for use with compatible ENT electrodes and accessories, providing clinicians with precise energy control during minimally invasive surgical procedures.
Key Features
Applications
Specifications
| Specification | Details |
|---|---|
| Product Type | ENT RF Plasma Surgical System |
| Category | Surgical & ICU Equipment |
| Technology | Radiofrequency (RF) Plasma |
| Primary Function | Tissue Coagulation & Ablation |
| Energy Type | RF Energy |
| Control | Adjustable Energy Output |
| Accessories | Compatible Plasma Electrodes & Cables |
| Application | ENT Surgery |
| Design | Professional Electrosurgical System |
| Operation | Clinical / Surgical Use |
| Intended Use | Professional Medical Use |
Be the first to review “ENT RF Plasma Surgical System / Plasma Coagulation Machine” Cancel reply






Reviews
There are no reviews yet.